Abstract
Innate immune responses follow accumulation of modified lipids within the arterial wall thereby influencing atherosclerotic plaque progression. One of the mechanisms evolved in maintaining immunologic self-tolerance involves upregulation of regulatory T-cells, among which the CD4+CD25+ FoxP3+ regulatory T-cells (Treg) are best characterized. The putative important role of Treg in the initiation of atherosclerotic lesions as well as in the progression towards unstable plaques leading to ischemic events, supported by human studies and, indirectly, by murine models. Herein, we summarize the experimental approaches taken in order to study the possible mechanisms of Treg involvement in atherosclerosis as well as the beneficial clinical potential of Treg in stabilizing atherosclerotic plaques.
Access provided by Autonomous University of Puebla. Download to read the full chapter text
Chapter PDF
Similar content being viewed by others
Keywords
- Treg Cell
- Atherosclerotic Lesion
- Unstable Plaque
- Human Atherosclerotic Plaque
- Human Atherosclerotic Lesion
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Hansson GK. Inflammation, atherosclerosis and coronary artery disease. N Engl J Med 2005; 352(16):1685–95.
Hansson GK, Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 2006; 6(7):508–19.
Benagiano M, Azzurri A, Ciervo A et al. T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions. Proc Natl Acad Sci USA 2003; 100(11):6658–63.
Frostegård J, Ulfgren AK, Nyberg P et al. Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis 1999; 145(1):33–43.
Hansson GK, Robertson AK, Soderberg-Naucler C. Inflammation and atherosclerosis. Annu Rev Parhol 2006; 1:297–329.
Kleindienst R, Xu Q, Willeit J et al. Immunology of atherosclerosis._Demonstration of heat shock protein 60 expression and T-lymphocytes bearing alpha/beta or gamma/delta receptor in human atherosclerotic lesions. Am J Pathol 1993; 142(6):1927–37.
Stemme S, Holm J, Hansson GK. T-lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1. Arterioscler Thromb 1992; 12(2):206–11.
Jonasson L, Holm J, Skalli O et al. Regional accumulations of T-cells, macrophages and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 1986; 6(2):131–8.
van der Wal AC, Das PK, Bentz van de Berg D et al. Atherosclerotic lesions in humans. In situ immunophenotypic analysis suggesting an immune mediated response. Lab Invest 1989; 61(2):166–70.
Choi JI, Chung SW, Kang HS et al. Establishment of Porphyromonas gingivalis heat-shock-protein-specific T-cell lines from atherosclerosis patients. J Dent Res 2002; 81(5):344–8.
Metzler B, Mayr M, Dietrich H et al. Inhibition of arteriosclerosis by T-cell depletion in normocholesterolemic rabbits immunized with heat shock protein 65. Arterioscler Thromb Vasc Biol 1999; 19(8):1905–11.
Stemme S, Faber B, Holm J et al. T-lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc Natl Acad Sci USA 1995; 92(9):3893–7.
Gotsman I, Gupta R, Lichtman AH. The influence of the regulatory T-lymphocytes on atherosclerosis. Arterioscler Thromb Vasc Biol 2007; 27(12):2493–5.
Fehervari Z, Sakaguchi S. CD4+ Tregs and immune control. J Clin Invest 2004; 114(9):1209–17.
Gorelik L, Flavell RA. Transforming growth factor-beta in T-cell biology. Nat Rev Immunol 2002; 2(1):46–53.
Sakaguchi S. Naturally arising CD4+ regulatory T-cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004; 22:531–62.
Miyara M, Sakaguchi S. Natural regulatory T-cells: mechanisms of suppression. Trends Mol Med 2007; 13(3):108–16.
Ronchetti S, Zollo O, Bruscoli S et al. GITR, a member of the TNF receptor superfamily, is costimulatory to mouse T-lymphocyte subpopulations. Eur J Immunol 2004; 34(3):613–22.
Huang CT, Workman CJ, Flies D et al. Role of LAG-3 in regulatory T-cells. Immunity 2004; 21(4):503–13.
Huehn J, Siegmund K, Lehmann JC et al. Developmental stage, phenotype and migration distinguish naive-and effector/memory-like CD4+ regulatory T-cells. J Exp Med 2004; 199(3):303–13.
Yurchenko E, Tritt M, Hay V et al. CCR5-dependent homing of naturally occurring CD4+ regulatory T-cells to sites of Leishmania major infection favors pathogen persistence. J Exp Med 2006; 203(11):2451–60.
Apostolou I, Sarukhan A, Klein L et al. Origin of regulatory T-cells with known specificity for antigen. Nat Immunol 2002; 3(8):756–63.
Paust S, Lu L, McCarty N et al. Engagement of B7 on effector T-cells by regulatory T-cells prevents autoimmune disease. Proc Natl Acad Sci USA 2004; 101(28):10398–403.
Pandiyan P, Zheng L, Ishihara S et al. CD4+CD25+Foxp3+ regulatory T-cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T-cells. Nat Immunol 2007; 8(12):1353–62.
Collison LW, Workman CJ, Kuo TT et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 2007; 450(7169):566–9.
Li MO, Sanjabi S, Flavell RA. Transforming growth factor-beta controls development, homeostasis and tolerance of T-cells by regulatory T-cell-dependent and-independent mechanisms. Immunity 2006; 25(3):455–71.
Marie C, Liggitt D, Rudensky AY. Cellular mechanisms of fatal early-onset autoimmunity in mice with the T-cell-specific targeting of transforming growth factor-beta receptor. Immunity 2006; 25(3):441–54.
Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T-cells. Nat Immunol 2003; 4(4):330–6.
Hori S, Nomura T, Sakaguchi S. Control of regulatory T-cell development by the transcription factor Foxp3. Science 2003; 299(5609):1057–61.
Brunkow ME, Jeffery EW, Hjerrild KA et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 2001; 27(1):68–73.
Gambineri E, Torgerson TR, Ochs HD. Immune dysregulation, polyendocrinopathy, enteropathy and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr Opin Rheumatol 2003; 15(4):430–5.
Roncador G, Brown PJ, Maestre L et al. Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T-cells at the single-cell level. Eur J Immunol 2005; 35(6):1681–91.
Lages CS, Suffia I, Velilla PA et al. Functional regulatory T-cells accumulate in aged hosts and promote chronic infectious disease reactivation. J Immunol 2008; 181(3):1835–48.
Zhou X, Jeker LT, Fife BT et al. Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity. J Exp Med 2008; 205(9):1983–91.
Curiel TJ. Regulatory T-cell development: is Foxp3 the decider? Nat Med 2007; 13(3):250–3.
George J, Shoenfeld Y, Harats D._The involvement of beta2-glycoprotein I (beta2-GPI) in human and murine atherosclerosis. J Autoimmun 1999; 13(1):57–60.
Palinski W, Rosenfeld ME, Ylä-Herttuala S et al. Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci USA 1989; 86(4):1372–6.
Xu Q, Luef G, Weimann S et al. Staining of endothelial cells and macrophages in atherosclerotic lesions with human heat-shock protein-reactive antisera. Arterioscler Thromb 1993; 13(12):1763–9.
George J, Afek A, Gilburd B et al. Cellular and humoral immune responses to heat shock protein 65 are both involved in promoting fatty-streak formation in LDL-receptor deficient mice. J Am Coll Cardiol 2001; 38(3):900–5.
George J, Harats D, Gilburd B et al. Adoptive transfer of beta(2)-glycoprotein I-reactive lymphocytes enhances early atherosclerosis in LDL receptor-deficient mice. Circulation 2000; 102(15):1822–7.
Zhou X, Nicoletti A, Elhage R et al. Transfer of CD4(+) T-cells aggravates atherosclerosis in immuno-deficient apolipoprotein E knockout mice. Circulation 2000; 102(24):2919–22.
Harats D, Yacov N, Gilburd B et al. Oral tolerance with heat shock protein 65 attenuates Mycobacterium tuberculosis-induced and high-fat-diet-driven atherosclerotic lesions. J Am Coll Cardiol 2002; 40(7):1333–8.
Maron R, Sukhova G, Faria AM et al. Mucosal administration of heat shock protein-65 decreases atherosclerosis and inflammation in aortic arch of low-density lipoprotein receptor-deficient mice. Circulation 2002; 106(13):1708–15.
van Puijvelde GH, van Es T, van Wanrooij EJ et al. Induction of oral tolerance to HSP60 or an HSP60-peptide activates T-cell regulation and reduces atherosclerosis. Arterioscler Thromb Vasc Biol 2007; 27(12):2677–83.
Almeida AR, Legrand N, Papiernik M et al. Homeostasis of peripheral CD4+ T-cells: IL-2R alpha and IL-2 shape a population of regulatory cells that controls CD4+ T-cell numbers. J Immunol 2002; 169(9):4850–60.
Zhang SH, Reddick RL, Piedrahita JA et al. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 1992; 258(5081):468–71.
Mallat Z, Gojova A, Brun V et al. Induction of a regulatory T-cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice. Circulation 2003; 108(10):1232–7.
Stoll G, Bendszus M. Inflammation and atherosclerosis: novel insights into plaque formation and destabilization. Stroke 2006; 37(7):1923–32.
Ishibashi S, Goldstein JL, Brown MS et al. Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. J Clin Invest 1994; 93(5):1885–93.
Ait-Oufella H, Salomon BL, Potteaux S et al. Natural regulatory T-cells control the development of atherosclerosis in mice. Nat Med 2006; 12(2):178–80.
Mor A, Planer D, Luboshits G et al. Role of naturally occurring CD4+ CD25+ regulatory T-cells in experimental atherosclerosis. Arterioscler Thromb Vase Biol 2007; 27(4):893–900.
Buono C, Pang H, Uchida Y et al. B7-1/B7-2 costimulation regulates plaque antigen-specific T-cell responses and atherogenesis in low-density lipoprotein receptor-deficient mice. Circulation 2004; 109(16):2009–15.
Gotsman I, Grabie N, Gupta R et al. Impaired regulatory T-cell response and enhanced atherosclerosis in the absence of inducible costimulatory molecule. Circulation 2006; 114(19):2047–55.
Zhang L, Peppel K, Sivashanmugam P et al. Expression of tumor necrosis factor receptor-1 in arterial wall cells promotes atherosclerosis. Arterioscler Thromb Vase Biol 2007; 27(5):1087–94.
Ben-Shoshan J, Maysel-Auslender S, Mor A et al. Hypoxia controls CD4+CD25+ regulatory T-cell homeostasis via hypoxia-inducible facror-1alpha. Eur J Immunol 2008; 38(9):2412–8.
Schwartz SM, Galis ZS, Rosenfeld M E et al. Plaque rupture in humans and mice. Arterioscler Thromb Vase Biol 2007; 27(4):705–13.
Naghavi M, Libby P, Falk E et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. Circulation 2003; 108(15):1772–8.
Naghavi M, Libby P, Falk E et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation 2003; 108(14):1664–72.
Hosono M, de Boer OJ, van der Wal AC et al. Increased expression of T-cell activation markers (CD25, CD26, CD40L and CD69) in atherectomy specimens of patients with unstable angina and acute myocardial infarction. Atherosclerosis 2003; 168(1):73–80.
van der Wal AC, Piek JJ, de Boer OJ et al. Recent activation of the plaque immune response in coronary lesions underlying acute coronary syndromes. Heart 1998; 80( 1):14–8.
Mor A, Luboshits G, Planer D et al. Altered status of CD4(+)CD25(+) regulatory T-cells in patients with acute coronary syndromes. Eur Heart J 2006; 27(21):2530–7.
Sardella G, De Luca L, Francavilla V et al. Frequency of naturally-occurring regulatory T-cells is reduced in patients with ST-segment elevation myocardial infarction. Thromb Res 2007; 120(4):631–4.
de Boer OJ, van der Meer JJ, Teeling P et al. Low numbers of FOXP3 positive regulatory T-cells are present in all developmental stages of human atherosclerotic lesions. PLoS ONE 2007; 2(1):e779.
De Palma R, Del Galdo F, Abbate G et al. Patients with acute coronary syndrome show oligoclonal T-cell recruitment within unstable plaque: evidence for a local, intracoronary immunologic mechanism. Circulation 2006; 113(5):640–6.
Shevach EM._From vanilla to 28 flavors: multiple varieties of T regulatory cells. Immunity 2006; 25(2):195–201.
Mausner-Fainberg K, Luboshits G, Mor A et al. The effect of HMG-CoA reductase inhibitors on naturally occurring CD4+CD25+ T-cells. Atherosclerosis 2008; 197(2):829–39.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Landes Bioscience and Springer+Business Media
About this chapter
Cite this chapter
Entin-Meer, M., Afek, A., George, J. (2009). Regulatory T-Cells, FoxP3 and Atherosclerosis. In: Maiese, K. (eds) Forkhead Transcription Factors. Advances in Experimental Medicine and Biology, vol 665. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-1599-3_8
Download citation
DOI: https://doi.org/10.1007/978-1-4419-1599-3_8
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-1598-6
Online ISBN: 978-1-4419-1599-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)